MORE►
Ben Lamm
Fatu in front and Najin in back are the last two known northern white rhinos alive on the planet. They live at Ol Pejeta conservancy in Kenya. [Photo: Ami Vitale]
Edge of Extinction: Pioneering Texas Biotech Colossal and BioRescue Race to Save the Northern White Rhino Species
by Quincy Preston and Lance Murray | Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
by Quincy Preston |
Aug 22, 2023
Dating apps can be a great way to find romance. But increasingly, according to the Wall Street Journal, users are finding something else instead: business come-ons from tech recruiters, networkers, children's book authors, and more.
MORE►
by Quincy Preston and Lance Murray |
Aug 22, 2023
Hypergiant Industries, a pioneering AI defense platform, finds a strategic match in its acquisition by Dallas's Trive Capital. Dallas Co-Founder Ben Lamm and CEO Mike Betzer both champion the shared vision of next-gen AI technologies bolstering national defense and critical infrastructure.
MORE►
by David Seeley |
Jun 21, 2023
Featuring "a diverse group of businesses helping chart an essential path forward," the TIME100 Most Influential Companies list features five companies that are either headquartered in North Texas or have a strong presence here. See who they are—and what they're doing to disrupt the status quo and innovate for the future.
MORE►
Hypergiant Co-Founder Ben Lamm [Image: Hypergiant]
Hypergiant Awarded Over $16M from U.S. Air Force for Cloud-Based Command and Control UX
by David Seeley | May 5, 2023
Hypergiant Galactic Systems Founder and Board Member Ben Lamm—who's also the co-founder and CEO of Texas-based Colossal Biosciences—tweeted out six rocket emojis to congratulate the Hypergiant team.
MORE►
by David Seeley |
Jan 31, 2023
Colossal says its efforts could help boost "the U.S. high-tech advantage." Its gene editing technologies "will make waves across sectors—in agriculture with new biofuels and preserving biodiversity, as well as in human health through improved gene therapy and vaccine development," the company said.
MORE►
by Lance Murray |
Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
MORE►
by Lance Murray |
Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas.
Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE►
Colossal co-founder and CEO Ben Lamm. [Image: Colossal]
The Last Word: Colossal’s Ben Lamm on Seeing His Startup Fuel a ‘Jeopardy’ Answer
by David Seeley | Oct 3, 2022
In August, Colossal Biosciences announced it is working to "de-extinct" the Tasmanian tiger with the help of an Australian university and “marsupial biobanking.” It didn't take long for the TV show "Jeopardy" to notice—and work it into an answer.
MORE►
by Kevin Cummings |
Sep 30, 2022
In this week’s North Texas deal flow, you’ll also find news about crowdfunding platform Harvest Return landing $2.5M; Supply’s acquisition by Foundry Brands; Moss Adams acquiring local CPA firm Kurtz & Company P.C.; Tri Global Energy being acquired for $270M by Canada's Enbridge; and more.
MORE►
by Kevin Cummings |
Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE►
by David Seeley |
Aug 16, 2022
Colossal is already working to "de-extinct" the woolly mammoth via a mammoth-elephant hybrid project. Now the Tasmanian tiger—which went extinct nearly 100 years ago due to human hunting—is the second species Colossal is seeking to bring back.
"We’re thrilled to be collaborating with Andrew Pask and the University of Melbourne to restore this amazing animal to Earth," said Ben Lamm, Colossal's co-founder and CEO.
MORE►
Colossal leadership team, L to R: Peter Phillips, chief business officer; Andrew Busey, chief product officer; Sarah Grant, chief of staff; Ben Lamm, co-founder/CEO; George Church, PhD, co-founder; Eriona Hysolli, head of biological sciences; Kent Wakeford, COO; and Brian Beard, chief legal officer. [Photo credit: John Davidson Photography]
Mammoth Project: Dallas’ Colossal Raises $60M to Advance Genetic Engineering and ‘De-Extinction’ Technologies
by Quincy Preston and David Seeley | Mar 9, 2022
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid.
With a total raise of $75 million to date, the startup aims to
have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE►
by David Seeley |
Dec 3, 2021
The Eos—a refrigerator-sized green energy solution powered by machine intelligence—captures and sequesters carbon from the atmosphere using algae. Hypergiant founder Ben Lamm, who's trying to bring back the woolly mammoth with his new startup Colossal, looks back at the development of Eos, and what it could mean for the world.
MORE►
by David Seeley |
Sep 13, 2021
It's not "Jurassic Park," but it's almost as amazing. Hypergiant founder Ben Lamm is launching a new biosciences and genetics startup—Colossal—with $15 million in private funding. The goal: Use genomics to "de-extinct" the woolly mammoth and re-wild it on the Arctic tundra. Lamm's co-founder, Harvard geneticist Dr. George Church, says this "grand vision" could lead to big opportunities in conservation, biodiversity, carbon sequestration, and more.
MORE►
by Alex Edwards |
May 18, 2021
Software executive Mike Betzer will lead the next phase of Hypergiant's growth, including a rollout of the industry's first system that provides open AI integration for building AI models.
Founder Ben Lamm, who launched Hypergiant from stealth in 2018, will pursue "the most pressing issues of our lifetime": AI for good, climate change, and the positive impact of technology. "This is where the world needs my time and attention," he says.
Founder Ben Lamm, who launched Hypergiant from stealth in 2018, will pursue "the most pressing issues of our lifetime": AI for good, climate change, and the positive impact of technology. "This is where the world needs my time and attention," he says.
MORE►
